Helena Thörn
- Pulmonary and Respiratory Medicine
- Pharmaceutical Science top 5%
- Oncology
- Pharmacology top 10%
- Molecular Biology
- Co-authors
- Erik SjögrenHans LennernäsChrister TannergrenPaul A. DickinsonJ. A. SchrickxAnna LundahlPer BäckmanMohammed Yasin
- Topics
- Inhalation and Respiratory Drug Delivery (6 papers)Pharmacogenetics and Drug Metabolism (5 papers)Drug Solubulity and Delivery Systems (5 papers)
- Journals
- European Journal of Pharmaceutics and BiopharmaceuticsDrug Metabolism and DispositionMolecular Pharmaceutics
- Partner nations
- SwedenUnited KingdomNetherlands
In The Last Decade
Helena Thörn
12 papers receiving 254 citations
Peers
Comparison fields: 5 of 58
- Pulmonary and Respiratory Medicine 96
- Pharmaceutical Science 87
- Oncology 69
- Pharmacology 51
- Molecular Biology 41
Countries citing papers authored by Helena Thörn
This map shows the geographic impact of Helena Thörn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Thörn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Thörn more than expected).
Fields of papers citing papers by Helena Thörn
This network shows the impact of papers produced by Helena Thörn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Thörn. The network helps show where Helena Thörn may publish in the future.
Co-authorship network of co-authors of Helena Thörn
This figure shows the co-authorship network connecting the top 25 collaborators of Helena Thörn. A scholar is included among the top collaborators of Helena Thörn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Thörn. Helena Thörn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 18 | |
| 3 | 18 | |
| 4 | 22 | |
| 5 | 21 | |
| 6 | 31 | |
| 7 | 66 | |
| 8 | 11 | |
| 9 | 4 | |
| 10 | First-pass Intestinal Metabolism of Drugs : Experiences from in vitro, in vivo and simulation studies | 2 |
| 11 | 51 | |
| 12 | 15 |
About Helena Thörn
Helena Thörn is a scholar working on Pharmaceutical Science, Pharmacology and Pulmonary and Respiratory Medicine, having authored 12 papers that have together received 260 indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Drug Solubulity and Delivery Systems (5 papers). The work is most often cited by research in Pharmaceutical Science (87 citations), Pharmacology (51 citations) and Pulmonary and Respiratory Medicine (96 citations). Helena Thörn has collaborated with scholars based in Sweden, United Kingdom and Netherlands. Frequent co-authors include Erik Sjögren, Hans Lennernäs, Christer Tannergren, Paul A. Dickinson, J. A. Schrickx, Anna Lundahl, Per Bäckman, Mohammed Yasin, Rebecca Fransson and Patrik Andersson. Their work appears in journals such as European Journal of Pharmaceutics and Biopharmaceutics, Drug Metabolism and Disposition and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.